Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Enliven Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −5 vs. Q1 2022
- Shares held
- 10.6M
- −3.30M (−23.7%) vs. Q1 2022
- Total value
- $13.1M
- −$13.1M (−50.0%) vs. Q1 2022
- New holders
- 3
- 4 more added
- Sold out
- 8
- 11 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 84 | $0 | 0.00% | +6+7.7% | Added |
| Royal Bank of Canada | 32 | $0 | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 3,742 | $5.00K | 0.00% | −96−2.5% | Reduced |
| Panagora Asset Management Inc | 11,451 | $14.0K | 0.00% | +11,451 | New |
| Northern Trust Corp | 15,314 | $19.0K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 18,000 | $21.0K | 0.00% | +18,000 | New |
| State Street Corp | 21,198 | $26.0K | 0.00% | 00.0% | Unchanged |
| Great Valley Advisor Group, Inc. | 21,011 | $26.0K | 0.00% | 00.0% | Unchanged |
| Tudor Investment Corp Et Al | 51,892 | $63.0K | 0.00% | −31−0.1% | Reduced |
| Bank of New York Mellon Corp | 52,419 | $64.0K | 0.00% | −17,273−24.8% | Reduced |
| Geode Capital Management, LLC | 55,739 | $68.0K | 0.00% | +1,276+2.3% | Added |
| Marquette Asset Management, LLC | 78,579 | $96.0K | 0.03% | +78,579 | New |
| Morgan Stanley | 92,094 | $112.0K | 0.00% | −9,840−9.7% | Reduced |
| Susquehanna International Group, LLP | 98,209 | $120.0K | 0.00% | −19,970−16.9% | Reduced |
| Two Sigma Investments, LP | 119,137 | $145.0K | 0.00% | −125,007−51.2% | Reduced |
| BlackRock Inc. | 122,961 | $150.0K | 0.00% | +15,565+14.5% | Added |
| Bridgeway Capital Management, LLC | 126,500 | $154.0K | 0.00% | −15,500−10.9% | Reduced |
| Two Sigma Advisers, LP | 182,800 | $223.0K | 0.00% | −101,200−35.6% | Reduced |
| Vanguard Group Inc | 265,687 | $324.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 407,520 | $497.0K | 0.00% | −42,980−9.5% | Reduced |
| Rock Springs Capital Management LP | 842,402 | $1.03M | 0.03% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 872,581 | $1.06M | 0.00% | +39,007+4.7% | Added |
| Lion Point Capital, LP | 834,780 | $1.14M | 0.41% | 00.0% | Unchanged |
| Woodline Partners LP | 951,293 | $1.16M | 0.02% | −73,724−7.2% | Reduced |
| NEA Management Company, LLC | 1,006,722 | $1.23M | 0.06% | −2,301,371−69.6% | Reduced |
| OrbiMed Advisors LLC | 4,386,568 | $5.35M | 0.10% | 00.0% | Unchanged |
| FMR LLC | 0 | $0 | 0.00% | −370,159−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −196,635−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −155,183−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −19,545−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,307−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −830−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −112−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −337−100.0% | Sold out |